{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:15:42Z","timestamp":1778051742664,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41375-026-02937-y","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:46:29Z","timestamp":1775040389000},"page":"1058-1061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New insights into JAK2 germline variant-driven stromal cell alterations and proinflammatory bone marrow niche remodeling in myeloproliferative neoplasms"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3788-8897","authenticated-orcid":false,"given":"Komei","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1774-7843","authenticated-orcid":false,"given":"Ryoichi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-4256","authenticated-orcid":false,"given":"Keiki","family":"Nagaharu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5455-401X","authenticated-orcid":false,"given":"Takuya","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ikejiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7944-7213","authenticated-orcid":false,"given":"Akihide","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0037-7049","authenticated-orcid":false,"given":"Tetsuya","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5426-9422","authenticated-orcid":false,"given":"Isao","family":"Tawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3263-3270","authenticated-orcid":false,"given":"Yuka","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8136-9907","authenticated-orcid":false,"given":"Kohshi","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2937_CR1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1056\/NEJMc1200349","volume":"366","author":"AJ Mead","year":"2012","unstructured":"Mead AJ, Rugless MJ, Jacobsen SE, Schuh A. Germline JAK2 mutation in a family with hereditary thrombocytosis. N Engl J Med. 2012;366:967\u20139.","journal-title":"N Engl J Med"},{"key":"2937_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/ng.341","volume":"41","author":"D Olcaydu","year":"2009","unstructured":"Olcaydu D, Harutyunyan A, J\u00e4ger R, Berg T, Gisslinger B, Pabinger I, et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet. 2009;41:450\u20134.","journal-title":"Nat Genet"},{"key":"2937_CR3","doi-asserted-by":"crossref","unstructured":"Zimolova V, Burocziova M, Berkova L, Grusanovic S, Gursky J, Janotka L, et al. Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation. Leukemia. 2025;39:2745\u201357.","DOI":"10.1038\/s41375-025-02737-w"},{"key":"2937_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2025.2513190","volume":"30","author":"K Nagaharu","year":"2025","unstructured":"Nagaharu K, Ono R, Nakano E, Nakamura A, Iwayama R, Ikejiri M, et al. A rare CALR exon 9 mutation p.E379Vfs*53 in AYA generation exhibits gain-of-function nature and can induce essential thrombocythemia; a case report. Hematology. 2025;30:2513190.","journal-title":"Hematology"},{"key":"2937_CR5","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/leu.2013.167","volume":"27","author":"I Khan","year":"2013","unstructured":"Khan I, Huang Z, Wen Q, Stankiewicz MJ, Gilles L, Goldenson B, et al. AKT is a therapeutic target in myeloproliferative neoplasms. Leukemia. 2013;27:1882\u201390.","journal-title":"Leukemia"},{"key":"2937_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/366583a0","volume":"366","author":"O Silvennoinen","year":"1993","unstructured":"Silvennoinen O, Ihle JN, Schlessinger J, Levy DE. Interferon-induced nuclear signalling by Jak protein tyrosine kinases. Nature. 1993;366:583\u20135.","journal-title":"Nature"},{"key":"2937_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1182\/blood-2002-04-1268","volume":"101","author":"Y Kawano","year":"2003","unstructured":"Kawano Y, Kobune M, Yamaguchi M, Nakamura K, Ito Y, Sasaki K, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood. 2003;101:532\u201340.","journal-title":"Blood"},{"key":"2937_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2141.2012.09109.x","volume":"157","author":"Y Nakamori","year":"2012","unstructured":"Nakamori Y, Liu B, Ohishi K, Suzuki K, Ino K, Matsumoto T, et al. Human bone marrow stromal cells simultaneously support B and T\/NK lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesis. Br J Haematol. 2012;157:674\u201386.","journal-title":"Br J Haematol"},{"key":"2937_CR9","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.4049\/jimmunol.1700054","volume":"199","author":"H Minami","year":"2017","unstructured":"Minami H, Nagaharu K, Nakamori Y, Ohishi K, Shimojo N, Kageyama Y, et al. CXCL12-CXCR4 axis is required for contact-mediated human B lymphoid and plasmacytoid dendritic cell differentiation but not T lymphoid generation. J Immunol. 2017;199:2343\u201355.","journal-title":"J Immunol"},{"key":"2937_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111260","volume":"40","author":"K Nagaharu","year":"2022","unstructured":"Nagaharu K, Kojima Y, Hirose H, Minoura K, Hinohara K, Minami H, et al. A bifurcation concept for B-lymphoid\/plasmacytoid dendritic cells with largely fluctuating transcriptome dynamics. Cell Rep. 2022;40:111260.","journal-title":"Cell Rep"},{"key":"2937_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/bjh.17396","volume":"193","author":"K Aoki","year":"2021","unstructured":"Aoki K, Kurashige M, Ichii M, Higaki K, Sugiyama T, Kaito T, et al. Identification of CXCL12-abundant reticular cells in human adult bone marrow. Br J Haematol. 2021;193:659\u201368.","journal-title":"Br J Haematol"},{"key":"2937_CR12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1182\/bloodadvances.2023011338","volume":"8","author":"S Rai","year":"2024","unstructured":"Rai S, Zhang Y, Grockowiak E, Kimmerlin Q, Hansen N, Stoll CB, et al. IL-1\u03b2 promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells. Blood Adv. 2024;8:1234\u201349.","journal-title":"Blood Adv"},{"key":"2937_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.gene.2006.08.027","volume":"386","author":"BP Thampatty","year":"2007","unstructured":"Thampatty BP, Li H, Im HJ, Wang JH. EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment. Gene. 2007;386:154\u201361.","journal-title":"Gene"},{"key":"2937_CR14","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1182\/blood-2016-02-698951","volume":"128","author":"K Kapralova","year":"2016","unstructured":"Kapralova K, Horvathova M, Pecquet C, Fialova Kucerova J, Pospisilova D, Leroy E, et al. Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia. Blood. 2016;128:1418\u201323.","journal-title":"Blood"},{"key":"2937_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijbiomac.2022.12.121","volume":"229","author":"F Li","year":"2023","unstructured":"Li F, Lu ZY, Xue YT, Liu Y, Cao J, Sun ZT, et al. Molecular basis of JAK2 H608Y and H608N mutations in the pathology of acute myeloid leukemia. Int J Biol Macromol. 2023;229:247\u201359.","journal-title":"Int J Biol Macromol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02937-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:26:39Z","timestamp":1778048799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02937-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2937"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-02937-y","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"YS reports honoraria from PharmaEssentia Japan KK, Novartis Pharmaceutical, GSK, and research funds under contract from Incyte Biosciences Japan, Toyo Kohan KK, MSD, Sumitomo Pharma Co., Ltd, Sobi Japan. K Nagaharu reports research funds under Takeda Pharmaceutical internationals. KO reports research funds under contract from PharmaEssentia Japan KK, Abbvie Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}